Tempest Therapeutics (TPST) Revenue (2015 - 2018)
Tempest Therapeutics (TPST) posted Revenue of $55000.0 for Q3 2018, down 32.1% sequentially from $81000.0 in Q2 2018, and down 1.79% YoY from $56000.0 in Q3 2017.
Tempest Therapeutics (TPST) Revenue (2015 - 2018) Analysis & Trends
Tempest Therapeutics has reported Revenue for 4 years, with the latest figure at $55000.0 in Q3 2018.
- Quarterly Revenue fell 1.79% year-over-year to $55000.0 in Q3 2018, while the trailing twelve-month figure through Sep 2018 was $294000.0 (down 9.26% YoY) and the FY2017 annual result came in at $295000.0, down 54.82% from the prior year.
- Revenue slipped to $55000.0 in Q3 2018 per TPST's latest filing, from $81000.0 in the prior quarter.
- Over five years, Revenue peaked at $197000.0 in Q3 2016 and troughed at $15000.0 in Q1 2015.
- A 4-year average of $95133.3 and a median of $81000.0 in 2018 frame the typical range for Revenue.
- The sharpest annual moves came in 2016 and 2017: Revenue jumped 873.33% in 2016, then tumbled 71.57% in 2017.
- Over 4 years, Revenue stood at $157000.0 in 2015, then retreated by 22.93% to $121000.0 in 2016, then retreated by 24.79% to $91000.0 in 2017, then slumped by 39.56% to $55000.0 in 2018.
- According to Business Quant data, Revenue over the past three periods registered $55000.0, $81000.0, and $67000.0 for Q3 2018, Q2 2018, and Q1 2018 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | Tempest Therapeutics | 4.23 Mn | 3.43 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 55,000.00 |
| Jun 30, 2018 | 81,000.00 |
| Mar 31, 2018 | 67,000.00 |
| Dec 31, 2017 | 91,000.00 |
| Sep 30, 2017 | 56,000.00 |
| Jun 30, 2017 | 84,000.00 |
| Mar 31, 2017 | 63,000.00 |
| Dec 31, 2016 | 121,000.00 |
| Sep 30, 2016 | 197,000.00 |
| Jun 30, 2016 | 189,000.00 |
| Mar 31, 2016 | 146,000.00 |
| Dec 31, 2015 | 157,000.00 |
| Sep 30, 2015 | 75,000.00 |
| Jun 30, 2015 | 30,000.00 |
| Mar 31, 2015 | 15,000.00 |